Showing results (61-70 of 3,858) with videos related to
Sort By:
Pageof 386
The Journal of Organic Chemistry|February 7, 2018
(3+2) Cycloadditions of Thiouronium Ylides: A Room-Temperature, One-Pot Approach to DihydrothiophenesJames D Neuhaus, Peter Angyal, Rik Oost, et al.Angewandte Chemie (International Ed. in English)|September 29, 2018
A Catalytic Cross-Olefination of Diazo Compounds with Sulfoxonium YlidesJames D Neuhaus, Adriano Bauer, Alexandre Pinto, et al.Klinische Padiatrie|May 1, 1981
[Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)]K Welte, U Ebener, L Hinderfeld, et al.Medical and Pediatric Oncology|November 26, 1999
Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trialsK Seidemann, M Tiemann, G Henze, et al.Pediatric Blood & Cancer|November 2, 2005
Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcomaC Furth, H Amthauer, T Denecke, et al.Onkologie|August 1, 1984
[Childhood B-cell lymphomas and leukemias. Improvement of prognosis by a therapy developed for B-neoplasms by the BFM study group]S Müller-Weihrich, G Henze, H J Langermann, et al.Klinische Padiatrie|July 1, 1991
[Long-term study of anthracycline-induced cardiomyopathy in children and adolescents]H Koch, L Schmitz, K Brockmeier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemiaC Wolfrom, R Hartmann, R Fengler, et al.Bone Marrow Transplantation|November 1, 1996
Which children do benefit from bone marrow transplant? The EBMT Paediatric Diseases Working PartyD Niethammer, T Klingebiel, W Ebell, et al.Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|January 1, 1990
[Long-term experiences with central venous catheters in pediatric oncology]P Hadjilaskari, S Brühmüller, R Fengler, et al.Pageof 386